摘要 |
Methods are disclosed herein for assaying a biological sample or a bodily fluid obtained from a subject by isolating, obtaining or using a microvesicle fraction from the biological sample or bodily fluid and detecting in the microvesicle fraction the presence or absence of a genetic aberration in an IDH1, IDH2, TP53, PTEN, CDKN2A, NF1, EGFR, RB1, PIK3CA, or BRAF gene. The methods may be used for aiding the diagnosis, prognosis, monitoring, or therapy selection in relation to a disease or other medical condition (e.g., a glioma) in a subject. |
申请人 |
THE GENERAL HOSPITAL CORPORATION;CHEN, WALTER;BREAKEFIELD, XANDRA O.;BALAJ, LEONORA;SKOG, JOHAN KARL OLOV |
发明人 |
CHEN, WALTER;BREAKEFIELD, XANDRA O.;BALAJ, LEONORA;SKOG, JOHAN KARL OLOV |